Contamination with adventitious viral agents in tissue culture cells, especially endogenous viruses in primary cells, has been known for many years; examples include simian viruses in monkey kidney cells (4) , guinea pig herpesvirus in guinea pig kidney or embryo cells (6) , and equine herpesvirus in horse kidney cells (5) . In continuous cell lines, endogenous retroviruses have been reported (7) . In addition, adventitious viral agents in bovine serum, which is an essential major component of cell culture medium, have been reported (1) (2) (3) (8) (9) (10) . Since routine quality control procedures for bovine serum used for tissue culture medium now include screening for viruses of bovine origin, mycoplasmas, and other contaminants (1) , adventitious viral contamination in tissue culture introduced by contaminated bovine serum is not frequently encountered. In this communication, isolation and identification of an infectious bovine rhinotracheitis virus (IBRV) contaminant from a commercially supplied A549 cell culture and its impact on the diagnosis of infections in clinical specimens are described.
During the week of 7 October 1991, one lot of A549 cells from a commercial supplier was inadvertently contaminated by a viral agent. Many laboratories received this lot of A549 cells for laboratory tests without knowledge of the contamination. A few days after specimen inoculation into this lot of A549 cells, six viral isolates from six separate specimens were obtained in our laboratory (lab A) ( Table 1) . These six specimens were three eye swabs obtained during an outbreak of epidemic keratoconjunctivitis, one throat swab, one lip lesion swab, and one rectal aspirate. The cytopathic effects (CPE) of these six isolates in A549 cells were similar, consisting of characteristic rounding with some syncytial formation which somewhat resembled the CPE induced by herpes simplex virus (HSV). On the basis of the characteristic CPE and specimen sources, immunofluorescence assays using monoclonal antibody to HSV-1 and HSV-2 (Syva Co., Palo Alto, Calif.), polyclonal antibody against HSV (Whittaker Bioproducts, Walkersville, Md.), monoclonal antibodies to varicella-zoster virus (Ortho Diagnostic Systems, Inc., Raritan, N.J.), and respiratory syncytial virus and adenovirus group antigen (Centers for Diseases Control) were performed repeatedly, but no viruses could be identified.
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In the meantime, the second laboratory (lab B), with which we collaborate in many areas, had a virus isolate in the same lot of A549 cells from a bronchoalveolar lavage of a bone marrow transplant patient with an undiagnosed severe pneumonitis. The isolate could not be identified by routine immunofluorescence assays using monoclonal antibody to HSV-1 and HSV-2 (Syva Co.) and adenovirus group antigen (Centers for Disease Control) ( Table 1) . Because of the urgent situation, the laboratory (lab B) reported to the physician the possible isolation of HSV on the basis of CPE alone, which was not its routine procedure. Acyclovir treatment of this patient was initiated. Over the following 2 days, the laboratory personnel of lab B observed a similar atypical CPE in A549 cultures inoculated with specimens from six other patients, including a bone marrow aspirate, a throat swab, an esophagus biopsy specimen, and three stool specimens (Table 1) , and in two uninoculated tubes of A549 cells. Contamination of A549 cells with an adventitious viral agent was then suspected. The commercial supplier and the patient's physician were notified that an adventitious agent was present in the A549 cell cultures.
During the same period, a third laboratory (lab C) sent an isolate to lab A for identification by electron microscopy, since lab C was unable to identify it by routine procedures. This isolate was also obtained from the same lot of A549 cells from the same commercial supplier. Lab C also kept uninfected cells from each lot for negative controls, but no spontaneous cell degeneration in their uninfected A549 control cell cultures in that particular lot was observed.
In order to identify the viral contaminant, electron microscopic examination of the supernatants of the infected cell cultures negatively stained with potassium phosphotungstate was performed, and a herpesviruslike particle was observed. Subsequently, six isolates grown in A549 cells, five from lab A and one from lab C, were fixed in 2% buffered glutaraldehyde, postfixed in osmium tetroxide, and embedded in Epon as described previously (3). Thin sections were cut, stained with uranyl acetate and lead citrate, and examined with an electron microscope. Herpesvirus particles with similar cellular changes were found in all six cases (Fig. 1) . The virus was finally identified by direct immunofluorescence assay using fluorescein isothiocyanate-conjugated goat anti-bovine rhinotracheitis virus immunoglobulin G (Colorado Serum Co. Laboratories, Denver, Colo.).
Immediately after the identification of IBRV, the five suspected until the discovery of cells in two uninoculated A549 tubes from lab B with similar viral CPE.
Electron microscopic examination was an essential step in providing a quick primary identification of the unknown agent. According to the commercial supplier, the source of the IBRV contamination was thought to be the calf serum used in freezing the seed stocks of A549 cells. This calf serum had been tested by an independent laboratory for adventitious bovine viruses, but no virus had been detected. To prevent the reoccurrence of this problem, the company destroyed the existing stock of A549 cells, obtained a new starter seed from the American Type Culture Collection, removed the lot of fetal bovine serum used, and revised the standard operation procedure for sterility and viability testing of frozen seed stocks to include observation of cells for CPE (6a 
Revised Nomenclature of Alloiococcus otitis
The species named Alloiococcus otitis by Aguirre and Collins (1, 2) should be renamed Aloiococcus otitidis. Rule 12c of the Bacteriological Code (3) states that a specific epithet must be treated as an adjective, as a substantive in apposition in the nominative case, or as a substantive in the genitive case. "A. otitis" would belong to the second category ("otitis," the nominative case, meaning "ear inflammation"), but such a combination does not make sense from a grammatical point of view. Rather, the genitive case, i.e., Aloiococcus otitidis ("of the ear inflammation"), analogous to Neisseria meningitidis or Pseudomonas pseudomallei, must be applied to this new species.
